The effect of a novel high-adherence weight loss programme
Research type
Research Study
Full title
The effect of a novel high-adherence weight loss programme in achieving weight loss and other health benefits
IRAS ID
361106
Contact name
Charles Howard
Contact email
Sponsor organisation
eMed Healthcare UK Ltd
ISRCTN Number
ISRCTN12421711
Duration of Study in the UK
1 years, 2 months, 1 days
Research summary
This study is designed to assess the effectiveness and acceptability of a novel weight management programme (the “Programme”).
The Programme is structured around a mobile application, and aims to provide a high-adherence model of care, support and guidance to participants in order to lose weight. Participants may also be prescribed medication to support their weight loss efforts as part of the Programme where this is deemed clinically appropriate following individual clinical review. The Programme involves regular check-ins including weight, side effect monitoring, blood tests and questionnaires.
The Programme is already established and collects information on participation, outcomes, satisfaction, side effects, blood test data and other questionnaires as part of usual treatment. This study is designed to retrospectively analyze this routinely-collected data in order to draw conclusions concerning the effectiveness and acceptability of the Programme.
The duration of the study is six months. Patients will be followed up for a further six months.
REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
25/PR/0927
Date of REC Opinion
24 Jul 2025
REC opinion
Unfavourable Opinion